STOCK TITAN

Pharming Group N.V. (PHAR) Net Income by Year

PHAR

Pharming Group N.V. reported $2.5M in net income in fiscal year 2025. This represents an increase of 121.4% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Pharming Group N.V. has filed alongside them.

FY2025 annual
Net Income $2.5M
YoY +121.4%
5Y CAGR -41.7%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PHAR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-KFY2010-KFY1910-K
Net Income$2.5M+121.4%-$11.8M-12.3%-$10.5M-177.1%$13.7M-14.5%$16.0M-57.6%$37.7M-6.9%$40.6M

PHAR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ4'1910-K
Net IncomeN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Pharming Group N.V. financials

Frequently Asked Questions

What was Pharming Group N.V.'s net income in fiscal year 2025?

Pharming Group N.V. reported $2.5M in net income in fiscal year 2025.

How fast is Pharming Group N.V.'s net income growing?

Pharming Group N.V. (PHAR) net income rose by 121.4% year over year, from -$11.8M to $2.5M in fiscal year 2025.

How has Pharming Group N.V.'s net income changed over the years?

Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) net income went from $40.6M in fiscal year 2019 to $2.5M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.